These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28727543)

  • 1. Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications.
    Zhou M; Leung A; Echegaray S; Gentles A; Shrager JB; Jensen KC; Berry GJ; Plevritis SK; Rubin DL; Napel S; Gevaert O
    Radiology; 2018 Jan; 286(1):307-315. PubMed ID: 28727543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.
    Gevaert O; Xu J; Hoang CD; Leung AN; Xu Y; Quon A; Rubin DL; Napel S; Plevritis SK
    Radiology; 2012 Aug; 264(2):387-96. PubMed ID: 22723499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between CT based radiomics features and gene expression data in non-small cell lung cancer.
    Wang T; Gong J; Duan HH; Wang LJ; Ye XD; Nie SD
    J Xray Sci Technol; 2019; 27(5):773-803. PubMed ID: 31450540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation.
    Rizzo S; Raimondi S; de Jong EEC; van Elmpt W; De Piano F; Petrella F; Bagnardi V; Jochems A; Bellomi M; Dingemans AM; Lambin P
    Eur J Radiol; 2019 Jan; 110():148-155. PubMed ID: 30599853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yamamoto S; Huang D; Du L; Korn RL; Jamshidi N; Burnette BL; Kuo MD
    Radiology; 2016 Jul; 280(1):261-70. PubMed ID: 27082783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBX3/heterochromatin protein 1 gamma is significantly upregulated in patients with non-small cell lung cancer.
    Chang SC; Lai YC; Chen YC; Wang NK; Wang WS; Lai JI
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e283-e288. PubMed ID: 29124886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous Enhancement Patterns of Tumor-adjacent Parenchyma at MR Imaging Are Associated with Dysregulated Signaling Pathways and Poor Survival in Breast Cancer.
    Wu J; Li B; Sun X; Cao G; Rubin DL; Napel S; Ikeda DM; Kurian AW; Li R
    Radiology; 2017 Nov; 285(2):401-413. PubMed ID: 28708462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues 
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
    Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
    Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
    Hsu PC; Jablons DM; Yang CT; You L
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated integrin α6β4 expression is associated with venous invasion and decreased overall survival in non-small cell lung cancer.
    Stewart RL; West D; Wang C; Weiss HL; Gal T; Durbin EB; O'Connor W; Chen M; O'Connor KL
    Hum Pathol; 2016 Aug; 54():174-83. PubMed ID: 27107458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
    Stewart EL; Mascaux C; Pham NA; Sakashita S; Sykes J; Kim L; Yanagawa N; Allo G; Ishizawa K; Wang D; Zhu CQ; Li M; Ng C; Liu N; Pintilie M; Martin P; John T; Jurisica I; Leighl NB; Neel BG; Waddell TK; Shepherd FA; Liu G; Tsao MS
    J Clin Oncol; 2015 Aug; 33(22):2472-80. PubMed ID: 26124487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
    Zhang Q; Sun T; Kang P; Qian K; Deng B; Zhou J; Wang R; Jiang B; Li K; Liu F; Wu S; Tan Q
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):583-93. PubMed ID: 26842788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
    Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
    Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radiogenomic dataset of non-small cell lung cancer.
    Bakr S; Gevaert O; Echegaray S; Ayers K; Zhou M; Shafiq M; Zheng H; Benson JA; Zhang W; Leung ANC; Kadoch M; Hoang CD; Shrager J; Quon A; Rubin DL; Plevritis SK; Napel S
    Sci Data; 2018 Oct; 5():180202. PubMed ID: 30325352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
    Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
    Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
    Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
    Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization.
    Yamamoto S; Korn RL; Oklu R; Migdal C; Gotway MB; Weiss GJ; Iafrate AJ; Kim DW; Kuo MD
    Radiology; 2014 Aug; 272(2):568-76. PubMed ID: 24885982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of periostin isoform pattern in non-small cell lung cancer.
    Morra L; Rechsteiner M; Casagrande S; von Teichman A; Schraml P; Moch H; Soltermann A
    Lung Cancer; 2012 May; 76(2):183-90. PubMed ID: 22079858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.